Detalhe da pesquisa
1.
Transfer of Cell-Surface Antigens by Scavenger Receptor CD36 Promotes Thymic Regulatory T Cell Receptor Repertoire Development and Allo-tolerance.
Immunity
; 48(5): 923-936.e4, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29752065
2.
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy.
Blood
; 139(8): 1177-1183, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34797911
3.
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 22(1D): e240001, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244272
4.
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis.
Blood
; 138(3): 273-282, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34292325
5.
Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(12): 1281-1301, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38081133
6.
A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft-versus-host disease.
Br J Haematol
; 198(4): 729-739, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35689489
7.
Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial.
Blood
; 135(20): 1739-1749, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32160294
8.
Transfer of Cell-Surface Antigens by Scavenger Receptor CD36 Promotes Thymic Regulatory T Cell Receptor Repertoire Development and Allo-tolerance.
Immunity
; 48(6): 1271, 2018 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29924978
9.
Targeting a deubiquitinase blocks GVHD.
Blood
; 141(12): 1376-1377, 2023 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951887
10.
DCEP and bendamustine/prednisone as salvage therapy for quad- and penta-refractory multiple myeloma.
Ann Hematol
; 99(5): 1041-1048, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32130471
11.
The effect of donor type on outcomes in adults with acute myeloid leukemia after reduced-intensity hematopoietic peripheral blood cell transplant - a retrospective study.
Transpl Int
; 33(9): 1089-1098, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32468720
12.
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
N Engl J Med
; 375(21): 2023-2036, 2016 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27959731
13.
Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft.
Blood
; 129(19): 2680-2692, 2017 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28292947
14.
Azacitidine Mitigates Graft-versus-Host Disease via Differential Effects on the Proliferation of T Effectors and Natural Regulatory T Cells In Vivo.
J Immunol
; 198(9): 3746-3754, 2017 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28330901
15.
The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia.
Biol Blood Marrow Transplant
; 24(6): 1125-1134, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29289756
16.
Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high-risk MDS: Phase 2 study results.
Am J Hematol
; 93(11): 1301-1310, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30074259
17.
Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome.
Biol Blood Marrow Transplant
; 23(10): 1736-1743, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28688919
18.
T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia.
Biol Blood Marrow Transplant
; 23(4): 648-653, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28087457
19.
Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) versus Filgrastim (Neupogen) in Combination with Plerixafor for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 23(12): 2065-2069, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28797783
20.
Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy.
Haematologica
; 107(7): 1709-1713, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35236053